Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcelo L G Correia

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Diabetes, Obesity & Metabolism|October 10, 2006
Role of leptin in the cardiovascular and endocrine complications of metabolic syndromeMarcelo L G Correia, Kamal Rahmouni
Expert Opinion on Emerging Drugs|August 9, 2005
Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelinesMarcelo L G Correia, William G Haynes
Arteriosclerosis, Thrombosis, and Vascular Biology|September 23, 2006
A role for plasminogen activator inhibitor-1 in obesity: from pie to PAI?Marcelo L G Correia, William G Haynes
Current Hypertension Reports|May 7, 2004
Obesity-related hypertension: is there a role for selective leptin resistance?Marcelo L G Correia, William G Haynes
Current Diabetes Reports|August 10, 2007
Arterial compliance and endothelial functionMarcelo L G Correia, William G Haynes
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|February 11, 2005
Loss of leptin actions in obesity: two concepts with cardiovascular implicationsAllyn L Mark, Marcelo L G Correia, Kamal Rahmouni, et al.
Hypertension (Dallas, Tex. : 1979)|December 8, 2004
Obesity-associated hypertension: new insights into mechanismsKamal Rahmouni, Marcelo L G Correia, William G Haynes, et al.
Journal of Hypertension|July 20, 2002
Selective leptin resistance: a new concept in leptin physiology with cardiovascular implicationsAllyn L Mark, Marcelo L G Correia, Kamal Rahmouni, et al.
Journal of Hypertension|July 20, 2002
Impaired skeletal muscle and skin microcirculatory function in human obesityAlexei V Agapitov, Marcelo L G Correia, Christine A Sinkey, et al.
American Journal of Hypertension|February 28, 2002
Hemodynamic consequences of neuropeptide Y-induced obesityMarcelo L G Correia, Donald A Morgan, William I Sivitz, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Diabetes, Obesity & Metabolism|October 10, 2006
Role of leptin in the cardiovascular and endocrine complications of metabolic syndromeMarcelo L G Correia, Kamal Rahmouni
Expert Opinion on Emerging Drugs|August 9, 2005
Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelinesMarcelo L G Correia, William G Haynes
Arteriosclerosis, Thrombosis, and Vascular Biology|September 23, 2006
A role for plasminogen activator inhibitor-1 in obesity: from pie to PAI?Marcelo L G Correia, William G Haynes
Current Hypertension Reports|May 7, 2004
Obesity-related hypertension: is there a role for selective leptin resistance?Marcelo L G Correia, William G Haynes
Current Diabetes Reports|August 10, 2007
Arterial compliance and endothelial functionMarcelo L G Correia, William G Haynes
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|February 11, 2005
Loss of leptin actions in obesity: two concepts with cardiovascular implicationsAllyn L Mark, Marcelo L G Correia, Kamal Rahmouni, et al.
Hypertension (Dallas, Tex. : 1979)|December 8, 2004
Obesity-associated hypertension: new insights into mechanismsKamal Rahmouni, Marcelo L G Correia, William G Haynes, et al.
Journal of Hypertension|July 20, 2002
Selective leptin resistance: a new concept in leptin physiology with cardiovascular implicationsAllyn L Mark, Marcelo L G Correia, Kamal Rahmouni, et al.
Journal of Hypertension|July 20, 2002
Impaired skeletal muscle and skin microcirculatory function in human obesityAlexei V Agapitov, Marcelo L G Correia, Christine A Sinkey, et al.
American Journal of Hypertension|February 28, 2002
Hemodynamic consequences of neuropeptide Y-induced obesityMarcelo L G Correia, Donald A Morgan, William I Sivitz, et al.
Pageof 2